FDA clears non-invasive insomnia-treating device from Neurovalens
Neurovalens announced today that the FDA granted clearance to its Modius Sleep device for treating chronic insomnia.
Belfast, Northern Ireland-based Neurovalens develops non-invasive neurotechnology. The company took part in the MedTech Innovator Accelerator program last year.
